Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

24.1%

7 terminated/withdrawn out of 29 trials

Success Rate

65.0%

-21.5% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

8%

1 of 13 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
9(75.0%)
Phase 4
1(8.3%)
Phase 3
1(8.3%)
Phase 2
1(8.3%)
12Total
N/A(9)
Phase 4(1)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials
NCT07556497Recruiting

Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes

Role: lead

NCT07515807Not Yet Recruiting

Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence

Role: lead

NCT07521033Not ApplicableCompleted

Development and Assessment of a 360° Video-Based Virtual Reality Application to Enhance Medical Students' Preparation for Initial Cadaver Dissection

Role: lead

NCT01483664Active Not Recruiting

Communication Skills Intervention to Promote Transition Into Survivorship

Role: collaborator

NCT02021734Completed

Genetics of Mendelian Diseases in Qatar

Role: collaborator

NCT07163000Active Not Recruiting

Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT)

Role: lead

NCT02879409Not ApplicableActive Not Recruiting

HbA1c Variability in Type II Diabetes

Role: lead

NCT05903950Not ApplicableRecruiting

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

Role: lead

NCT02660476Terminated

Qatar Universal Diabetes Outcomes (QUDOS) Study

Role: lead

NCT04573101Not ApplicableCompleted

EEG Responses to Arabic Music Scales

Role: lead

NCT02316522Completed

Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population

Role: collaborator

NCT02021695Completed

DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes

Role: collaborator

NCT03225339Not ApplicableCompleted

Diabetes Intervention Accentuating Diet and Enhancing Metabolism

Role: lead

NCT03518476Not ApplicableCompleted

Evaluation of an Intensive Education Program on the Treatment of Tobacco Use Disorder for Pharmacists: a Randomized Controlled Trial

Role: collaborator

NCT02648243Not ApplicableCompleted

Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar

Role: collaborator

NCT01172743Terminated

Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)

Role: collaborator

NCT02021721Terminated

Next Generation DNA Sequencing in Patients With Idiopathic Male Infertility

Role: collaborator

NCT04473131Unknown

Immune Profiling of COVID19-patients Admitted to ICU

Role: collaborator

NCT02765100Not ApplicableCompleted

Depression, Obesity and Inflammatory Markers

Role: collaborator

NCT03349840Phase 4Terminated

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Role: lead